Oncologists Reachable
~50K
Medical oncologists & hematologists in EQ5 datagraph
NPI Match Rate
90%++
vs. 40–60% industry standard
CPM All-In
$185
No hidden fees · publisher + serving included
Launch Speed
48 Hours
IO to first impressions in 2 business days
Audience Architecture
NPI Universe
2.2M
All specialty HCPs nationally in EQ5 datagraph
NPI Match Rate
90%++
Industry avg 40–60% for oncology HCPs
Specialty Depth
~50K
Medical oncologists & hematologists reachable
Merck Brand Target Specialty EQ5 NPI Cohort Est. Reachable HCPs
Keytruda (pembrolizumab) Oncology — multi-tumor Medical Oncologists, Hematologists ~50,000
Keytruda — Dermatology Dermatologic Oncology Dermatologists, Mohs Surgeons ~18,000
Gardasil Vaccines / Preventive Ob/Gyns, Pediatricians, Family Medicine ~90,000
Immunology Pipeline Immunology / Autoimmune Rheumatologists, Dermatologists, Gastroenterologists ~35,000
Channels
LinkedIn HCP Targeting
NPI-matched oncology & immunology HCPs in professional context
LinkedIn NPI-Matched
Meta HCP Targeting
Same NPI list deployed across Facebook & Instagram · peer & peer context
Meta NPI-Matched
Programmatic Display
$185 CPM all-in · 200+ premium medical publishers · physician-level reporting
Programmatic Analytics
Pipeline & Next Steps
Conversion Roadmap
Merck · Keytruda Portfolio
Lead Stage
1
Identify Priority Brand & HCP Universe
Select Keytruda tumor type or pipeline brand · define target prescriber list for NPI matching
2
Free NPI List Match — 90%+ match analysis
EQ5 runs a complimentary match against the Merck NPI list · no cost, no commitment · results delivered within 48 hours
3
Proof-of-Concept Pilot — 3-month $50K–$100K
Scoped pilot for one Keytruda tumor type or immunology brand · measurable reach, match rate, and physician-level NPI reporting
StatusProspect
StageLead
Org ID124
RepChad Holloway
Since2026
FocusOncology / Immunology
→ Request Keytruda NPI prescriber list
→ Run free NPI list match analysis — 48 hr turnaround
→ Deliver match report → pilot proposal